News
Podcast: Talking the cure
12 July 2024
Our team is always thinking about how to foresee and conquer the most significant industry issues facing our clients. In 2020, we launched the podcast "Talking the Cure" where we cover...
News
12 July 2024
Our team is always thinking about how to foresee and conquer the most significant industry issues facing our clients. In 2020, we launched the podcast "Talking the Cure" where we cover...
News
04 June 2024
In this alert, we provide a round-up of the latest developments in ESG for UK corporates.
News
23 May 2024
A recent English case may cause concern amongst Hong Kong auditors hoping to protect themselves from liability towards third parties by the inclusion of standard disclaimer wording in their ...
Insights and Analysis
07 May 2024
The Q1/24 Life Science and Health Care Law Update covers key trends across EU life sciences regulatory, corporate, compliance, competition, and privacy.Key new developments: Pharma: EC ...
News
30 April 2024
In this month’s round-up of the latest developments in ESG for UK clients, we cover: Belgium: Pioneer protecting the planet; David v Goliath: ClientEarth v Shell and the growing...
News
25 April 2024
On April 23, 2024, the Federal Trade Commission (FTC) voted to publish a final rule that, effective 120 days after publication, will ban the use of non-compete clauses nationwide,...
News
22 April 2024
The Accounting and Financial Reporting Council (AFRC) has published its first report on the public interest entity (PIE) audit market in Hong Kong. Reviewing its own survey of PIE auditors, ...
News
10 April 2024
In the latest edition of our Securities, Shareholder, and M&A Litigation Outlook for 2024, we analyze key developments from 2023 and discuss how the most important cases from Delaware...
News
24 March 2024
On March 6, 2024, the U.S. Securities and Exchange Commission adopted its highly anticipated rules requiring climate-related disclosures.